GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » YIFAN PHARMACEUTICAL CO LTD (SZSE:002019) » Definitions » Cyclically Adjusted FCF per Share

YIFAN PHARMACEUTICAL CO (SZSE:002019) Cyclically Adjusted FCF per Share : ¥0.20 (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is YIFAN PHARMACEUTICAL CO Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

YIFAN PHARMACEUTICAL CO's adjusted free cash flow per share for the three months ended in Mar. 2024 was ¥0.040. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.20 for the trailing ten years ended in Mar. 2024.

During the past 12 months, YIFAN PHARMACEUTICAL CO's average Cyclically Adjusted FCF Growth Rate was -9.10% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 1.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 22.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of YIFAN PHARMACEUTICAL CO was 88.20% per year. The lowest was 1.60% per year. And the median was 33.05% per year.

As of today (2024-05-26), YIFAN PHARMACEUTICAL CO's current stock price is ¥13.51. YIFAN PHARMACEUTICAL CO's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥0.20. YIFAN PHARMACEUTICAL CO's Cyclically Adjusted Price-to-FCF of today is 67.55.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of YIFAN PHARMACEUTICAL CO was 2275.00. The lowest was 43.70. And the median was 110.18.


YIFAN PHARMACEUTICAL CO Cyclically Adjusted FCF per Share Historical Data

The historical data trend for YIFAN PHARMACEUTICAL CO's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YIFAN PHARMACEUTICAL CO Cyclically Adjusted FCF per Share Chart

YIFAN PHARMACEUTICAL CO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.20 0.22 0.22 0.21

YIFAN PHARMACEUTICAL CO Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.22 0.21 0.21 0.20

Competitive Comparison of YIFAN PHARMACEUTICAL CO's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - General subindustry, YIFAN PHARMACEUTICAL CO's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


YIFAN PHARMACEUTICAL CO's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, YIFAN PHARMACEUTICAL CO's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where YIFAN PHARMACEUTICAL CO's Cyclically Adjusted Price-to-FCF falls into.



YIFAN PHARMACEUTICAL CO Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, YIFAN PHARMACEUTICAL CO's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.04/115.2271*115.2271
=0.040

Current CPI (Mar. 2024) = 115.2271.

YIFAN PHARMACEUTICAL CO Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.018 98.200 -0.021
201409 -0.024 98.900 -0.028
201412 0.032 99.000 0.037
201503 0.032 99.900 0.037
201506 0.005 99.500 0.006
201509 0.317 100.500 0.363
201512 0.005 100.600 0.006
201603 -0.033 102.200 -0.037
201606 0.116 101.400 0.132
201609 0.222 102.400 0.250
201612 0.218 102.600 0.245
201703 0.039 103.200 0.044
201706 0.197 103.100 0.220
201709 0.173 104.100 0.191
201712 0.162 104.500 0.179
201803 0.205 105.300 0.224
201806 0.153 104.900 0.168
201809 0.090 106.600 0.097
201812 -0.081 106.500 -0.088
201903 -0.123 107.700 -0.132
201906 -0.042 107.700 -0.045
201909 0.097 109.800 0.102
201912 0.125 111.200 0.130
202003 0.036 112.300 0.037
202006 0.342 110.400 0.357
202009 0.100 111.700 0.103
202012 -0.181 111.500 -0.187
202103 -0.029 112.662 -0.030
202106 -0.041 111.769 -0.042
202109 -0.080 112.215 -0.082
202112 -0.076 113.108 -0.077
202203 -0.151 114.335 -0.152
202206 0.108 114.558 0.109
202209 -0.006 115.339 -0.006
202212 -0.012 115.116 -0.012
202303 -0.096 115.116 -0.096
202306 0.013 114.558 0.013
202309 -0.008 115.339 -0.008
202312 -0.035 114.781 -0.035
202403 0.040 115.227 0.040

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


YIFAN PHARMACEUTICAL CO  (SZSE:002019) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

YIFAN PHARMACEUTICAL CO's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=13.51/0.2
=67.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of YIFAN PHARMACEUTICAL CO was 2275.00. The lowest was 43.70. And the median was 110.18.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


YIFAN PHARMACEUTICAL CO Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of YIFAN PHARMACEUTICAL CO's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


YIFAN PHARMACEUTICAL CO (SZSE:002019) Business Description

Traded in Other Exchanges
N/A
Address
No. 50 Qinshan, Jincheng, Lin'an Economic Development Zone, Hangzhou, Zhejiang, CHN, 311300
YIFAN PHARMACEUTICAL CO LTD is a China-based company engaged in pharmaceutical innovation and manufacturing. The company focuses its activities on key areas like macromolecular biologics, high-value pharmaceuticals, and differentiated traditional Chinese medicines. The products of the company are F-627 for Neutropenia and Parkinson's disease, F-652 for acute alcoholic hepatitis, GvHD and acute pancreatitis and F-899 for growth deficiency. The company's products are sold in China and internationally.
Executives
Ye Yi Qun Director
Zhang Da Wei Executives
Geng Yu Hong Executives
Feng De Qi Directors, Directors, and Executives
Zhou Ben Yu Director
Lin Xing Directors, executives
Yu Hai Xia Executives
Cheng Xian Feng Directors, executives
Xu Guo Han Supervisors
Cao Shi Mei Director
Lin Guan Yu Director
Zhang Lian Chun Executives
Guo Xin Fu Director
Zheng Shi Ming Supervisors
Yin Hang Hua Executives

YIFAN PHARMACEUTICAL CO (SZSE:002019) Headlines

No Headlines